Bristol Myers Squibb announces appointment of Dr Monica Shaw
Bristol Myers Squibb (BMS) has announced the appointment of Dr Monica Shaw as senior vice president of Major Markets, meaning she will oversee the company’s largest markets outside the US, including Canada and Western Europe.
Previously, Shaw worked as chief executive officer at Oncopeptides, and has held various leadership roles at GSK/ViiV healthcare, Merck Serono and Novartis; in these roles she has launched over 15 products through phase 3 to commercialisation. Her experience spans immunology, dermatology, oncology, virology, neurology and rare diseases.
Commenting on her appointment, Shaw stated: “My passion for science has always been rooted in how it could be used to help people and treat diseases. I’m very excited to join Bristol Myers Squibb at a pivotal time for the organisation as we renew our product portfolio, grow an already strong pipeline and bring new treatments to help patients with unmet needs.”
Adam Lenkowsky, BMS’s newly appointed executive vice president and chief commercial officer, stated: “We are thrilled to welcome Monica to our commercial leadership team as our new head of Major Markets. Monica is inspired by science-led, purpose-focused organisations and fuelled by a drive to increase patient access to medicines. With her vast international experience and successful track record in new launches, she is the perfect leader to help us deliver on our mission of developing new, transformational medicines that benefit patients with serious diseases across the globe.”